Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

BrainAurora Medical Technology / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/brainaurora-medical-technology-limited" target="_blank" data-smartkarma-citation="entities:40007:1" rel="noopener">BrainAurora Medical Technology (6681 HK)</a> announced the placement of 92M shares for subscription at HK$5.6 per share. Further the seller will subscribe for top-up subscription shares (92M shares @ HK$5.6).</li>
<li>BrainAurora intends to use the proceeds majorly for research and development initiatives, market development, investments, acquisitions and working capital purpose.  </li>
<li>BrainAurora still has a long way to go. The current share placement gives a good entry point given the near-term growth prospects, expansion efforts and the R&amp;D capabilities.</li>
</ul>



BrainAurora Medical Technology (6681 HK) announced the placement of 92M shares for subscription at HK$5.6 per share. Further the seller will subscribe for top-up subscription shares (92M shares @ HK$5.6).
BrainAurora intends to use the proceeds majorly for research and development initiatives, market development, investments, acquisitions and working capital purpose.  
BrainAurora still has a long way to go. The current share placement gives a good entry point given the near-term growth prospects, expansion efforts and the R&amp;D capabilities.


BrainAurora (6681 HK) Placement: A Good Entry Point Given the Growth Outlook, R&D Capabilities